FDA Authorizes Fourth Pfizer and Moderna Covid Vaccine Doses for People Age 50 and Older

Tiger Newspress2022-03-29

The Food and Drug Administration has authorized fourth Pfizer and Moderna Covid vaccine dose for everyone age 50 and older, amid uncertainty over whether an even more contagious version omicron will cause another wave of infection in the U.S. as it has in Europe and China.

The FDA also authorized a second Pfizer booster shot for people age 12 and older who have compromised immune systems, and a second Moderna booster for adults ages 18 and older with compromised immune systems. The new boosters are administered at least fourth months after the last shot.

The FDA made the decision without a meeting of its vaccine advisory committee, a rare move the agency has made more frequently over the course of the pandemic to expand uses of Covid vaccines. The drug regulator’s authorization comes just two weeks after Pfizer and Moderna asked the FDA to permit a second booster shot based on data from Israel. The Centers for Disease Control and Prevention is expected to quickly sign off on the decision.

The FDA’s decision effectively bypasses its advisory committee on vaccines, which is scheduled to meet on April 6 to discuss the future of booster shots in the U.S. The vaccine experts are expected to hold a broad discussion about boosters and will not vote on a specific recommendation.

Pfizer shares added nearly 1% while Moderna stock rose more than3% in morning trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Toby_Chua
    2022-03-30
    Toby_Chua
    Never ending jab drug companies laughing to the bank
  • Moonlightpig
    2022-03-30
    Moonlightpig
    Jab again
  • Kirton
    2022-03-30
    Kirton
    I wonder if we will continue to have a fifth, sixth and so on in terms of boosters. If so, then it's gonna be potentially recurring revenue for these vaccine makers, especially if governments continue to purchase them and administer them for free
  • Cvt
    2022-03-30
    Cvt
    Like
  • PearlynCSY
    2022-03-30
    PearlynCSY
    The more contagious omicron BA.2 subvariant is now the dominant version of Covid-19 in the U.S. as it accounts for nearly 55% of Covid cases, according to the CDC. BA.2 has doubled as a proportion of circulating variants of the virus in the U.S. about every two weeks. The BA.2 subvariant spreads about 75% faster than the earlier version of omicron, BA.1, The BA.2 subvariant spreads about 75% faster than the earlier version of omicron, BA.1, according to the latest update from U.K. Health Security Agency. 
  • YJ Lee
    2022-03-30
    YJ Lee
    Ok
Leave a comment
33